263 related articles for article (PubMed ID: 25303768)
1. Genetic delivery of an immunoRNase by an oncolytic adenovirus enhances anticancer activity.
Fernández-Ulibarri I; Hammer K; Arndt MA; Kaufmann JK; Dorer D; Engelhardt S; Kontermann RE; Hess J; Allgayer H; Krauss J; Nettelbeck DM
Int J Cancer; 2015 May; 136(9):2228-40. PubMed ID: 25303768
[TBL] [Abstract][Full Text] [Related]
2. Strong antitumor efficacy of a pancreatic tumor-targeting oncolytic adenovirus for neuroendocrine tumors.
Yamamoto Y; Nagasato M; Rin Y; Henmi M; Ino Y; Yachida S; Ohki R; Hiraoka N; Tagawa M; Aoki K
Cancer Med; 2017 Oct; 6(10):2385-2397. PubMed ID: 28941156
[TBL] [Abstract][Full Text] [Related]
3. Verapamil enhances the antitumoral efficacy of oncolytic adenoviruses.
Gros A; Puig C; Guedan S; Rojas JJ; Alemany R; Cascallo M
Mol Ther; 2010 May; 18(5):903-11. PubMed ID: 20179683
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-7-loaded oncolytic adenovirus improves CAR-T cell therapy for glioblastoma.
Huang J; Zheng M; Zhang Z; Tang X; Chen Y; Peng A; Peng X; Tong A; Zhou L
Cancer Immunol Immunother; 2021 Sep; 70(9):2453-2465. PubMed ID: 33543339
[TBL] [Abstract][Full Text] [Related]
5. Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth.
Tedcastle A; Illingworth S; Brown A; Seymour LW; Fisher KD
Mol Ther; 2016 Apr; 24(4):796-804. PubMed ID: 26708004
[TBL] [Abstract][Full Text] [Related]
6. Chorioallantoic Membrane Tumor Model for Evaluating Oncolytic Viruses.
Krutzke L; Allmendinger E; Hirt K; Kochanek S
Hum Gene Ther; 2020 Oct; 31(19-20):1100-1113. PubMed ID: 32552215
[TBL] [Abstract][Full Text] [Related]
7. Temozolomide renders murine cancer cells susceptible to oncolytic adenovirus replication and oncolysis.
Garza-Morales R; Yaddanapudi K; Perez-Hernandez R; Riedinger E; McMasters KM; Shirwan H; Yolcu E; Montes de Oca-Luna R; Gomez-Gutierrez JG
Cancer Biol Ther; 2018 Mar; 19(3):188-197. PubMed ID: 29252087
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral delivery of a Tim-3 antibody-encoding oncolytic adenovirus engages an effective antitumor immune response in liver cancer.
Qiang L; Huili Z; Leilei Z; Xiaoyan W; Hui W; Biao H; Yigang W; Fang H; Yiqiang W
J Cancer Res Clin Oncol; 2023 Dec; 149(20):18201-18213. PubMed ID: 38078962
[TBL] [Abstract][Full Text] [Related]
9. The role of JNK phosphorylation as a molecular target to enhance adenovirus replication, oncolysis and cancer therapeutic efficacy.
Wechman SL; Rao XM; Gomez-Gutierrez JG; Zhou HS; McMasters KM
Cancer Biol Ther; 2018; 19(12):1174-1184. PubMed ID: 30067431
[TBL] [Abstract][Full Text] [Related]
10. T-cell engager-armed oncolytic vaccinia virus significantly enhances antitumor therapy.
Yu F; Wang X; Guo ZS; Bartlett DL; Gottschalk SM; Song XT
Mol Ther; 2014 Jan; 22(1):102-11. PubMed ID: 24135899
[TBL] [Abstract][Full Text] [Related]
11. Systemic delivery of an oncolytic adenovirus expressing soluble transforming growth factor-β receptor II-Fc fusion protein can inhibit breast cancer bone metastasis in a mouse model.
Hu Z; Zhang Z; Guise T; Seth P
Hum Gene Ther; 2010 Nov; 21(11):1623-9. PubMed ID: 20712434
[TBL] [Abstract][Full Text] [Related]
12. Real-Time Fluorescence Image-Guided Oncolytic Virotherapy for Precise Cancer Treatment.
Yano S; Tazawa H; Kishimoto H; Kagawa S; Fujiwara T; Hoffman RM
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477279
[TBL] [Abstract][Full Text] [Related]
13. Potent antitumor efficacy of human dental pulp stem cells armed with YSCH-01 oncolytic adenovirus.
He X; Yao W; Zhu JD; Jin X; Liu XY; Zhang KJ; Zhao SL
J Transl Med; 2023 Oct; 21(1):688. PubMed ID: 37789452
[TBL] [Abstract][Full Text] [Related]
14. Enhanced cancer cell killing by truncated E2F-1 used in combination with oncolytic adenovirus.
Gomez-Gutierrez JG; Rao XM; Zhou HS; McMasters KM
Virology; 2012 Nov; 433(2):538-47. PubMed ID: 23021422
[TBL] [Abstract][Full Text] [Related]
15. Tumor-targeted delivery of copper-manganese biomineralized oncolytic adenovirus for colorectal cancer immunotherapy.
Li YS; Ye LY; Luo YX; Zheng WJ; Si JX; Yang X; Zhang YN; Wang SB; Zou H; Jin KT; Ge T; Cai Y; Mou XZ
Acta Biomater; 2024 Apr; 179():243-255. PubMed ID: 38458511
[TBL] [Abstract][Full Text] [Related]
16. Dual‑regulated oncolytic adenovirus carrying
Zhao T; Ye W; Zhang R; Zhu X; Shi Q; Xu X; Chen W; Xu L; Meng Y
Mol Med Rep; 2024 Jul; 30(1):. PubMed ID: 38757346
[TBL] [Abstract][Full Text] [Related]
17. Oncolytic Adenovirus for the Targeting of Paclitaxel-Resistant Breast Cancer Stem Cells.
Robert S; Roman Ortiz NI; LaRocca CJ; Ostrander JH; Davydova J
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675909
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin hydrochloride enhanced antitumour effect of CEA-regulated oncolytic virotherapy in live cancer cells and a mouse model.
Xiao B; Ying C; Chen Y; Huang F; Wang B; Fang H; Guo W; Liu T; Zhou X; Huang B; Liu X; Wang Y
J Cell Mol Med; 2020 Nov; 24(22):13431-13439. PubMed ID: 33251723
[TBL] [Abstract][Full Text] [Related]
19. Cell Membrane-Coated Oncolytic Adenovirus for Targeted Treatment of Glioblastoma.
Jia X; Wang L; Feng X; Liu W; Wang X; Li F; Liu X; Yu J; Yu B; Yu X
Nano Lett; 2023 Dec; 23(23):11120-11128. PubMed ID: 38032110
[TBL] [Abstract][Full Text] [Related]
20. Safety profiles and antitumor efficacy of oncolytic adenovirus coated with bioreducible polymer in the treatment of a CAR negative tumor model.
Jung SJ; Kasala D; Choi JW; Lee SH; Hwang JK; Kim SW; Yun CO
Biomacromolecules; 2015 Jan; 16(1):87-96. PubMed ID: 25400213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
